Skip to main content
Premium Trial:

Request an Annual Quote

Genicon Sciences, BD Biosciences Pen Microarray Collaboration

NEW YORK, Dec. 18 — Genicon Sciences is partnering with BD Biosciences Clontech to adapt its Resonance Light Scattering signal generation and detection technology for BD's microarrays.


The agreement, announced on Tuesday, gives Genicon Sciences the right to develop, manufacture, distribute, and promote its system for specific use on the BD Atlas group of microarrays. The system includes reagents, instrumentation, and analysis software.


In addition, BD Biosciences Clontech will promote Genicon's integrated assay system.


Financial details of the deal were not disclosed.


BD Biosciences Clontech, based in Palo Alto, Calif., manufactures pre-spotted glass microarrays containing up to 3,800 human, mouse, and rat DNA oligonucleotides.


Genicon Sciences, of San Diego, is a privately held company that focuses on assay technologies and development.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.